files/journal/2022-09-02_14-46-02-000000_263.png

Journal of Molecular Genetics

ISSN: Online
ISSN: Print 2070-4267
139
Views
0
Downloads

Presence of Type-I Gonadotropin Releasing Hormone Receptor Transcript and Protein in Ovary and Uterus of Goat (Capra hircus)

Kamal Kumar Saxena, Vimalkumar Mappilettu Balan, Anjani Kumar Srivastava and Atul Upreti
Page: 8-11 | Received 21 Sep 2022, Published online: 21 Sep 2022

Full Text Reference XML File PDF File

Abstract

Several subtypes of Gonadotropin Releasing Hormone (GnRH) and its receptor are known in non-mammalian vertebrates but the only functional GnRH receptor known in higher mammals so far is type-I GnRH receptor. Though GnRH is primarily known for its role in the regulation of gonadotropins (FSH and LH) secretion from the pituitary, it is also though to be an autocrine/paracrine regulator of ovarian functions. Receptor of gonadotropin releasing hormone is well studied in several animal species but no study has been made to explore the role of GnRH receptor in extrahypophysial tissues of goat. Here we report, for the first time the confirmation of expression of type-I GnRH receptor in the ovary and uterus of goat. The expression of this receptor in these tissues was confirmed by RT-PCR and western blotting.


INTRODUCTION

Gonadotropin releasing hormone receptor is a member of Rhodopsin like G protein coupled receptor super family (Choi et al., 2001; Sealfon et al., 1997). The GnRH receptor mediates the synthesis and release of FSH and LH in gonadotroph cell population of anterior pituitary. Though GnRH receptor is primarily found in anterior pituitary expression of this receptor is reported in several extrahypophysial tissues and human cell lines like Placenta cell line (Lin et al., 1995), prostate cancer line (Wang et al., 1996), ovary granulose cells (Latouche et al., 1989) and ovarian cancer cell lines (Bramley et al., 1987; Edine et al., 1985; Brus et al., 1997) breast carcinoma and mammary caner cell lines (Cui et al., 2000). Unlike other members of this superfamily, type-I GnRH receptor lacks the carboxyl terminal tail (Stojilkovic and Catt, 1995) which participates in several downstream reactions through several associated proteins (Bockaert et al., 2003; Emons et al., 1993). Though GnRH receptor and its subtypes are well studied in different animal species no study has been made to explore the role of GnRH receptor in extrahypophysial tissues of goat. In the present study GnRH receptor was amplified from goat ovary and uterus using RT-PCR to demonstrate it’s transcripts in extrahypophysial tissues. cDNA was synthesized from RNA isolated from ovary and uterus of goat. A 408 bp fragment corresponding to the position 81-488 of 987 bp open reading frame of the GnRH-R (coding amino acids 146-266) was amplified form goat ovary and uterus cDNA using specific primers designed to characterize this receptor from goat pituitary previously (Upreti et al., 2010). The expression of functional GnRH receptor protein in ovary and uterus of goat was further confirmed by western blotting. The membrane protein was isolated from ovary and uterus of goat and western blotting was performed using monoclonal antiserum raised in mouse against human GnRH receptor as primary antibody.

MATERIALS AND METHODS

RNA isolation and cDNA synthesis: Tissue samples were collected from local abattoir, immediately after slaughter in RNAlater solution (Qiagen, Germany). The total RNA from the ovary and uterus of goat was isolated using RNAeasy Kit (Qiagen) following the manufacturers protocol. The purity and integrity of RNA was confirmed by spectrophotometry and gel electrophoresis. The cDNA was synthesized from the RNA using MuMLV reverse transcriptase (MBI-Fermentas) and oligo-dT primers (MBI-Fermentas). For cDNA synthesis 20 μL reaction volume was prepared containing 5 μg of total RNA, 5 μg of oligo dT primer, 1 mM dNTP mix, 20 U of ribonuclease inhibitor and 20 U of MuMLV reverse transcriptase. The temperature conditions were followed as mentioned in manufacturer’s protocol.

PCR Amplification of type-I GnRH-R: A 408 bp fragment corresponding to the position 81-488 of 987 bp open reading frame of the GnRH-R (coding amino acids 146-266) was amplified form goat ovary and uterus cDNA using specific primers (forward 5′-GCCAAGCCAA-TCATGA ACTGTCC-3′ and reverse 5′GCCAAGCCAATCATGA ACTGTCC3′). Polymerase Chain Reaction (PCR) was carried out in 25 μL reaction volume containing ~70 ng of cDNA, 20 pM of each primer, 400 μM of dNTP mix, 2.5 unit of Taq DNA polymerase and 1.5 mM MgCl2 using T Personal Thermocycler. The PCR programme used to amplify 408 bp product involved initial denaturation at 95°C for 3 min, 32 cycles of denaturation at 95°C for 1 min, annealing at 50°C for 30 sec and extension at 72°C for 1 min followed by a final extension of 10 min at 72°C. The amplified PCR products were electrophorezised with 100 bp DNA ladder (MBI Fermentas) on ethidium bromide stained 1% agarose gel and were visualized under UV and photographed.

Protein isolation and western blotting: Membrane fraction of the protein was extracted from ovary and uterus of goat using method described by Karande et al. (1995). The 10% homogenate of tissue was prepared in extraction buffer (20 mM Tris-HCl pH 8.0, 10 mM NaCl, 1 mM CaCl2 and 1 mM PMSF). The homogenate was centrifuged at 800 g for 10 min to pellet down the cell debries, the centrifugation was repeated for 4 times. The resultant supernatant was centrifuged at 10,000 g for 30 min at 4°C the supernatant was discarded and the pellet was solubilized in CHAPS buffer (5 mM CHAPS in 10 mM Tris-HCl pH 7.4). Protein samples were electrophorized in 10% SDS polyacrylamide gel using standard protocol (Sambrook et al., 2001). The protein was transferred to the membrane by electro-blotting method using standard protocol (Sambrook et al., 2001). The membrane was blocked with 3% bovine serum albumin solution in wash buffer (50 mM Tris-HCl pH 7.5, 200 mM NaCl and 0.05% Tween 20) and then incubated in wash buffer containing F1G4 anti human GnRH-R mouse monoclonal antibody (courtesy Dr. A. Karanade I.I.Sc Bangalore India) followed by washing with wash buffer for several times. The membrane was then incubated in secondary antibody (IgG goat anti mouse AP conjugated, Bangalore Genei) and again washed with wash buffer for several times. The colour was developed with BCIP/NBT substrate solution (Ambion).

RESULTS AND DISCUSSION

RNA isolation, cDNA synthesis and PCR amplification: The RNA yield using RNeasy Mini Kit was found about 1.5 μg mg-1 of tissue and A260/280 of the RNA sample obtained was 1.88 indicating the high purity of the RNA samples. PCR with specific primer pair using cDNA from ovary and uterus RNA gave products of expected size (408 bp) confirming the presence of type I GnRH receptor transcript in ovary and uterus (Fig. 1).

Western blotting: The western blot analysis showed band corresponding ~62 KD in both ovary and uterus samples (Fig. 2).

Though GnRH is primarily known for its role in the regulation of gonadotropin secretion from the pituitary, the presence of GnRH and its receptor in the granulosa-luteal cells and ovarian surgace epithelial cells suggests that GnRH exerts its action in an autocrine/paracrine manner to modulate both basal and gonadotropin stimulated steiroidogenesis, folliculogenesis and luteolysis (Leung and Steele, 1992). Many workers believe that the presence of GnRH and it’s receptor in addition to regulating gonadotropins and identification of structural variants of GnRH in extrahypothalamic and detailed molecular delineation of the interaction of these extrahypophysial tissues indicates that these molecules have been co-opted during evolution for other functions GnRHs with the type I GnRH receptor and the selective activation of intracellular signals will contribute to the development of novel GnRH therapeutics (Millar et al., 2004).

Fig. 1: 408 bp PCR product from ovary and uterus of goat Lane M; molecular size marker, Lane1; 408 bp product from ovary, Lane 2; 408 bp PCR product from uterus

 

Fig. 2: Western blot of protein samples, O: Ovary, U: Uterus and M: Marker

 

Although, the presence of GnRH-R in the extrahypophysial tissues from various species have been suggested by studies using RT-PCR, the current findings represents the first report of the GnRH-R transcript and functional protein in extrahypophysial tissue sites of goat. In the present study the presence of GnRH-R in the ovary and uterus of goat was demonstrated by RT-PCR and western blotting. The 408 bp products of type I GnRH-R were amplified from cDNA prepared from total mRNA isolated from ovary and uterus of goat confirming the presence of type I GnRH receptor transcript in these tissues. The western blot analysis was performed to confirm the expression of functional protein in the ovary and uterus of goat. The extracted protein was analyzed by SDS-PAGE. Western blot revealed the band of 62 KD size representing the GnRH receptor protein both the samples. This finding is in accordance to other reports about the expression of GnRH receptor in extrahypophysial tissues suggesting it’s possible role in autocrine or paracrine regulation of reproductive processes beside the central hormonal axis (Sengupta and Sridaran, 2008). As expression of GnRH-I and GnRH-II mRNAs identical to their brain counter parts have been demonstrated in various ovarian tissues including Ganulosa-Luteal (GL) cells and the Ovarian Surface Epithelial (OSE) cells (Bourne et al., 1980; Grundker et al., 2002; Kang et al., 2000) the findings provide strong evidence that ovary and uterus are possible target organs for autocrin/paracrine functions of GnRH. Further research like studying the various levels of GnRHs and type-I GnRH receptor through out the ovarian cycle using quantitative PCR will explore the functional aspect of this receptor in these tissues which may help in understanding the possible action of GnRH analogs in extrahypophysial tissues of goat in addition to their effects on pituitary function.

CONCLUSION

The present study confirms the expression of type-I gonadotropin releasing hormone receptor in extrahypophysial tissues (ovary and uterus) of goat. This provides strong evidence that these tissues are target organs for gonadoreopin releasing hormone and this hormone has autocrine/paracrine functions which must be studied further to better understand the molecular mechanism of this hormone function.

ACKNOWLEDGEMENT

The researchers are thankful to Director, Indian Veterinary Research Institute Izatnagar Uttar Pradesh India for providing necessary research facilities.

How to cite this article:

Kamal Kumar Saxena, Vimalkumar Mappilettu Balan, Anjani Kumar Srivastava and Atul Upreti. Presence of Type-I Gonadotropin Releasing Hormone Receptor Transcript and Protein in Ovary and Uterus of Goat (Capra hircus).
DOI: https://doi.org/10.36478/jmolgene.2011.8.11
URL: https://www.makhillpublications.co/view-article/2070-4267/jmolgene.2011.8.11